News from the FDA/CDC

U.S. tops 10,000 confirmed monkeypox cases: CDC


 

The United States has now recorded more than 10,000 confirmed monkeypox cases, according to data released by the Centers for Disease Control and Prevention.

The United States passed the 10,000 mark on Aug. 10, with the number climbing to 10,768 by the morning of Aug. 12, according to the latest CDC data. Monkeypox cases have been found in every state except Wyoming. New York (2,187), California (1,892), and Florida (1,053) have reported the most cases. So far, no monkeypox deaths have been reported in the United States.

The numbers are increasing, with 1,391 cases reported in the United States on Aug. 12 alone, by far the most in 1 day since the current outbreak began.

“We are still operating under a containment goal, although I know many states are starting to wonder if we’re shifting to more of a mitigation phase right now, given that our case counts are still rising rapidly,” Jennifer McQuiston, DVM, the CDC’s top monkeypox official, told a group of the agency’s advisers on Aug. 9, according to CBS News.

Since late July, the United States has reported more monkeypox cases than any other nation. After the United States, Spain has reported 5,162 cases, the United Kingdom 3,017, and France 2,423, according to the World Health Organization.

Globally, 31,655 cases have been recorded, with 5,108 of those cases coming in the last 7 days, according to the WHO. There have been 12 deaths attributed to monkeypox, with one coming in the last week.

The smallpox-like disease was first found in humans in the Democratic Republic of the Congo in 1970 and has become more common in West and Central Africa. It began spreading to European and other Western nations in May 2022.

The WHO declared it a global public health emergency in late July, and the Biden administration declared it a national health emergency Aug. 4.

To fight the spread of monkeypox, the Biden administration is buying $26 million worth of SIGA Technologies Inc.’s IV version of the antiviral drug TPOXX, the company announced on Aug. 9.

U.S. health officials also modified monkeypox vaccine dosing instructions to stretch the supply of vaccine. Instead of sticking with a standard shot that would enter deep into tissue, the FDA now encourages a new way: just under the skin at one-fifth the usual dose.

A version of this article first appeared on WebMD.com.

Recommended Reading

Fungated Eroded Plaque on the Arm
MDedge Dermatology
Clinical characteristics of recurrent RIME elucidated in chart review
MDedge Dermatology
Should monkeypox be considered an STD? Experts debate
MDedge Dermatology
Monkeypox: Large study highlights new symptoms
MDedge Dermatology
Potentially deadly bacteria detected in U.S. soil
MDedge Dermatology
U.S. clears 786,000 monkeypox vaccine doses for distribution
MDedge Dermatology
COVID skin manifestations vary by type of variant, U.K. study finds
MDedge Dermatology
White House declares monkeypox a public health emergency
MDedge Dermatology
Climate change can worsen more than half of infectious diseases
MDedge Dermatology
In one state, pandemic tamped down lice and scabies cases
MDedge Dermatology